Max Robotics — Global Service Robot Directory + US Certification

About

John R. Mascola is a leading figure in viral immunology, best known for his pioneering work on HIV-1 antibody discovery and vaccine development. His research focuses on understanding the B-cell immune response to HIV-1, with the goal of designing vaccines that elicit broadly neutralizing antibodies (bnAbs). Mascola’s major contributions include the development of high-throughput microneutralization assays and the application of antibodyomics—bioinformatics tools that map the genetic and functional landscape of B-cell immunity. These technologies have enabled the isolation and characterization of numerous potent bnAbs from HIV-1-infected donors, providing critical blueprints for structure-based vaccine design. His work has been highly influential, with key papers accumulating over 37 and 21 citations, respectively. More recently, Mascola has extended his expertise to emerging viral threats, isolating cross-neutralizing antibodies from COVID-19 convalescent subjects, demonstrating the broader applicability of his methods. As the former Director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, his achievements have shaped the global effort toward an effective HIV-1 vaccine and informed rapid responses to pandemic coronaviruses.